Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane, Waldemar E. Wysokinski, Jennifer G. Le-Rademacher, Tyler Zemla, Aneel Ashrani, Alfonso Tafur, Usha Perepu, Daniel Anderson, Krishna Gundabolu, Charles Kuzma, Juliana Perez Botero, Roberto A. Leon Ferre, Stanislav Henkin, Charles J. Lenz, Damon E. Houghton, Prakash Vishnu, Charles L. Loprinzi

Research output: Contribution to journalArticle

39 Scopus citations

Fingerprint Dive into the research topics of 'Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences